5-(1-(4-Hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-2-oxo-2-phenylethyl)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione Full article
| Journal |
Molbank
ISSN: 1422-8599 |
||||
|---|---|---|---|---|---|
| Output data | Year: 2023, Volume: 2023, Number: 2, Article number : M1640, Pages count : DOI: 10.3390/m1640 | ||||
| Authors |
|
||||
| Affiliations |
|
Abstract:
Multicomponent reactions have been demonstrated as a promising tool for the creation of diverse molecular structures with enhanced efficiency, reduced waste, and a high atom economy. Arylglyoxal monohydrates with two different carbonyl groups are well known as worthwhile synthons in organic synthesis. 2-Pyrone and pyrimidine-2,4,6-trione are versatile building blocks for the synthesis of key intermediates in synthetic organic chemistry as well as in medicinal chemistry. A simple and efficient tandem Knoevenagel–Michael protocol for the synthesis of the previously unknown 5-(1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-2-oxo-2-phenylethyl)-1,3-dimet-hylpyrimidine-2,4,6(1H,3H,5H)-trione was elaborated. The suggested method is based on the multicomponent reaction of phenylglyoxal hydrate, 1,3-dimethylbarbituric acid, and 4-hydroxy-6-methyl-2H-pyran-2-one. The structure of the synthesized compound was proven by 1H, 13C-NMR, and IR spectroscopy, mass spectrometry, and elemental analysis. A procedure for predicting the possible types of its biological activity was carried out for the title compound.
Cite:
Ryzhkova Y.E.
, Kalashnikova V.M.
, Ryzhkov F.V.
, Elinson M.N.
5-(1-(4-Hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-2-oxo-2-phenylethyl)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione
Molbank. 2023. V.2023. N2. M1640 . DOI: 10.3390/m1640 WOS Scopus OpenAlex
5-(1-(4-Hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-2-oxo-2-phenylethyl)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione
Molbank. 2023. V.2023. N2. M1640 . DOI: 10.3390/m1640 WOS Scopus OpenAlex
Identifiers:
| ≡ Web of science: | WOS:001014632600001 |
| ≡ Scopus: | 2-s2.0-85163754368 |
| ≡ OpenAlex: | W4381793883 |